Viviane M Conraads
Overview
Explore the profile of Viviane M Conraads including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
79
Citations
1697
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Conraads V, Spruit M, Braunschweig F, Cowie M, Tavazzi L, Borggrefe M, et al.
Circ Heart Fail
. 2014 Feb;
7(2):279-87.
PMID: 24519908
Background: Physical activity (PA) predicts cardiovascular mortality in the population at large. Less is known about its prognostic value in patients with chronic heart failure (HF). Methods And Results: Data...
12.
Haine S, Van Craenenbroeck E, Hoymans V, Miljoen H, Vandendriessche T, Claeys M, et al.
Can J Cardiol
. 2013 Dec;
30(1):102-8.
PMID: 24365195
Background: Angiographic and clinical parameters are poor predictors of in-stent restenosis. Bone marrow-derived CD34(+) cells that coexpress a receptor for vascular endothelial growth factor (kinase insert domain receptor [KDR]) are...
13.
Denollet J, Pedersen S, Vrints C, Conraads V
Psychosom Med
. 2013 Oct;
75(9):873-81.
PMID: 24163388
Objective: Methodological considerations and selected null findings indicate the need to reexamine the Type D construct. We investigated whether associations with cardiac events in patients with coronary artery disease (CAD)...
14.
Van Berendoncks A, Stensvold D, Garnier A, Fortin D, Sente T, Vrints C, et al.
Eur J Prev Cardiol
. 2013 Oct;
22(2):203-5.
PMID: 24104889
Patients with metabolic syndrome are characterized by low circulating adiponectin levels and reduced adiponectin sensitivity in skeletal muscles. Through binding on its main skeletal muscle receptor AdipoR1, adiponectin activates AMP-activated...
15.
Bruyndonckx L, Radtke T, Eser P, Vrints C, Ramet J, Wilhelm M, et al.
Int J Cardiol
. 2013 Aug;
168(4):3183-90.
PMID: 23972967
Endothelial dysfunction is recognized as the primum movens in the development of atherosclerosis. Its crucial role in both cardiovascular morbidity and mortality has been confirmed. In the past, research was...
16.
van Ierssel S, Van Craenenbroeck E, Hoymans V, Vrints C, Conraads V, Jorens P
PLoS One
. 2013 Aug;
8(8):e69499.
PMID: 23936333
Background: Outcome in sepsis is mainly defined by the degree of organ failure, for which endothelial dysfunction at the macro- and microvascular level is an important determinant. In this study...
17.
Philipsen T, Vermeulen T, Conraads V, Rodrigus I
Interact Cardiovasc Thorac Surg
. 2013 Aug;
17(5):875-7.
PMID: 23900382
The left ventricular apical core biopsy performed during implantation of a left ventricular assist device (VAD) is a well-known diagnostic procedure in confirming cardiomyopathies leading to end-stage heart failure. We...
18.
Conraads V, Van Craenenbroeck E, Pattyn N, Cornelissen V, Beckers P, Coeckelberghs E, et al.
Int J Cardiol
. 2013 May;
168(4):3532-6.
PMID: 23711446
Background: Exercise-based cardiac rehabilitation is considered an important adjunct treatment and secondary prevention measure in patients with coronary artery disease (CAD). However, the issues of training modality and exercise intensity...
19.
Bruyndonckx L, Hoymans V, Van Craenenbroeck A, Vissers D, Vrints C, Ramet J, et al.
Oxid Med Cell Longev
. 2013 May;
2013:174782.
PMID: 23691262
The association of obesity with noncommunicable diseases, such as cardiovascular complications and diabetes, is considered a major threat to the management of health care worldwide. Epidemiological findings show that childhood...
20.
Van Craenenbroeck E, Conraads V, Greenlaw N, Gaudesius G, Mori C, Ponikowski P, et al.
Eur J Heart Fail
. 2013 May;
15(7):756-62.
PMID: 23639779
Aims: Red cell distribution width (RDW), a measure of variability in red blood cell size, is a novel prognostic marker in chronic heart failure (CHF). Iron deficiency contributes to elevated...